“During a year in which we have all faced unprecedented challenges, the response and commitment of our employees to maintain business continuity and serve our customers has been outstanding. The strength and quality of Croda’s business model has been further tested and proven. Whilst customer demand in certain end markets has inevitably been impacted by the pandemic, Croda’s financial performance has been resilient.
"Our strong financial platform has allowed us to make further progress positioning the business to focus on the fast growth markets of the future, capitalising on emerging trends in existing and adjacent markets. We have made significant investments to accelerate delivery of our strategy, notably the acquisitions of Avanti and Iberchem, so that life science and consumer markets now represent over 80% of Croda’s profit generation.
"I am more confident than ever that our recent acquisitions, relentless innovation and emphasis on sustainability will drive our future profitability.”
Steve Foots, Group Chief Executive
Latest News From Croda
About cookies on this site